Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Business Times.
Press releases published on March 27, 2025
CTO Realty Growth Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, May 1, 2025. A …
Alpine Income Property Trust Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, …
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
·
March 27, 2025
HORSHAM, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Jones Soda Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, April 1, 2025, at 9:00 a.m. ET
GlobeNewswire
·
March 27, 2025
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced it will hold a conference call on Tuesday, April 1, 2025, at 9:00 a.m. Eastern time to discuss its financial and …
SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 27, 2025
DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced …
Accolade Stockholders Approve Merger Between Accolade and Transcarent
GlobeNewswire
·
March 27, 2025
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, …
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
·
March 27, 2025
CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (CAB-AXL-ADC) Q2W dosing regimen associated with exceptional overall survival (OS) …
Hour Loop Reports Full Year 2024 Results
GlobeNewswire
·
March 27, 2025
Profitability Continues Despite Challenges for the Overall Economy Provides Full Year 2025 Revenue and Net Income Guidance Redmond, WA, March 27, 2025 (GLOBE NEWSWIRE) -- Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop”), a leading online retailer, announces …
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema Accepted for Regulatory Review in China - - Multiple …
Barfresh Provides Fourth Quarter and Full Year 2024 Results and Business Update
GlobeNewswire
·
March 27, 2025
Company Achieves Highest Fiscal Year Revenue in Company History Revenue of $10.7 Million, Gross Margin of 34% and Adjusted Gross Margin of 37% for Fiscal Year 2024 Pop …
The Lovesac Company Announces Fourth Quarter and Fiscal 2025 Conference Call Date
GlobeNewswire
·
March 27, 2025
STAMFORD, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its fourth quarter and fiscal 2025 financial results will be released …
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 27, 2025
MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
GlobeNewswire
·
March 27, 2025
– Initial clinical activity in a PD-(L)1 resistant population, with an ORR almost three times higher than historical PD-(L)1 rechallenge response rates, with data still maturing – – One durable complete response in a Merkel Cell Carcinoma (MCC) patient and …
NextNav Announces Closing of $190 Million of 5% Redeemable Senior Secured, Convertible Notes Transaction
GlobeNewswire
·
March 27, 2025
RESTON, Va., March 27, 2025 (GLOBE NEWSWIRE) -- NextNav Inc. (the "Company" or “NextNav”) [NASDAQ: NN], a leader in next-generation positioning, navigation, and timing (“PNT”) and 3D geolocation, today announced the successful closing of the previously …
Great Southern Bancorp, Inc. Announces First Quarter 2025 Preliminary Earnings Release Date and Conference Call
GlobeNewswire
·
March 27, 2025
SPRINGFIELD, Mo., March 27, 2025 (GLOBE NEWSWIRE) -- Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, expects to report first quarter preliminary earnings after the market closes on Wednesday, April 16, 2025, and …
AEON Biopharma Announces CEO Transition
GlobeNewswire
·
March 27, 2025
– Marc Forth Steps Down as President and CEO to Pursue Another Opportunity; will remain on the Board of Directors – – Jost Fischer, Chairman of AEON, will assume the role of interim CEO – IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, …
Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
GlobeNewswire
·
March 27, 2025
Expect Topline Phase 2 data for NDV-01 for high-grade non-muscle invasive bladder cancer (HG-NMIBC), to be presented at AUA 2025 in April Advancing novel neurosteroid, sepranolone, towards Phase 2b study in Tourette syndrome with plans for evaluation in …
Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 27, 2025
HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 27, 2025
MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial …
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth Quarter and Full-Year Fiscal 2024 Results
GlobeNewswire
·
March 27, 2025
ATLANTA, March 27, 2025 (GLOBE NEWSWIRE) -- Oxford Industries, Inc. (NYSE:OXM) today announced financial results for its fourth quarter and full fiscal year 2024 ended February 1, 2025 and initiated guidance for the first quarter and full fiscal year 2025. …